EIKEN CHEMICAL CO.,LTD. Logo

EIKEN CHEMICAL CO.,LTD.

Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.

4549 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
台東区台東四丁目19番9号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eiken Chemical Co., Ltd., founded in 1939, is a manufacturer specializing in clinical diagnostics. The company's core business involves the development, manufacturing, and sale of pharmaceuticals, reagents, and medical and scientific equipment. Eiken Chemical is a global leader in Fecal Immunochemical Test (FIT) systems, such as its OC-Sensor series, for the early detection of colorectal cancer. Its portfolio also includes microbiological tests for food poisoning bacteria and environmental inspection, serving the broader healthcare and research markets. The company provides comprehensive solutions from sample collection to result reporting for its diagnostic systems.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 07:32
Prospectus
発行登録書(株券、社債券等)
Japanese 32.0 KB
2025-08-08 09:09
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.0 KB
2025-07-10 08:23
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.4 KB
2025-06-25 03:09
Regulatory News Service
訂正発行登録書
Japanese 10.2 KB
2025-06-25 03:05
Regulatory News Service
臨時報告書
Japanese 32.3 KB
2025-06-25 03:00
Governance Information
内部統制報告書-第87期(2024/04/01-2025/03/31)
Japanese 27.1 KB
2025-06-25 03:00
Registration Form
有価証券報告書-第87期(2024/04/01-2025/03/31)
Japanese 2.0 MB
2025-06-25 03:00
Registration Form
確認書
Japanese 9.1 KB
2025-06-24 09:54
Registration Form
訂正発行登録書
Japanese 10.2 KB
2025-06-24 09:51
Share Issue/Capital Change
臨時報告書
Japanese 39.7 KB
2025-06-10 09:22
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 28.0 KB
2025-05-12 03:18
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 28.2 KB
2025-04-10 05:00
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.2 KB
2025-03-25 04:52
Registration Form
訂正発行登録書
Japanese 10.3 KB
2025-03-25 04:51
Regulatory News Service
訂正発行登録書
Japanese 10.3 KB

Automate Your Workflow. Get a real-time feed of all EIKEN CHEMICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for EIKEN CHEMICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Novartis AG Logo
Develops and markets innovative medicines globally using advanced science and technology.
Switzerland NOVN
Develops first-in-class drugs and supplements for metabolic and fibrotic diseases.
South Korea 229500
Novo Nordisk Logo
Develops medicines and devices for chronic diseases like diabetes, obesity, and rare disorders.
Denmark NOVO
NUFORMIX PLC Logo
Repurposing drugs for fibrosis and oncology using proprietary cocrystal technology.
United Kingdom NFX
NUTEX Investments Plc Logo
Develops & distributes health, cosmetic & pharma products from natural ingredients globally.
Hungary NUTEX
Nxera Pharma Co., Ltd. Logo
Biopharma using SBDD tech to develop medicines for neurology and gastroenterology.
Japan 4565
ObsEva SA Logo
Developed novel therapeutics for women's reproductive health and pregnancy.
Switzerland OBSN
ODI Pharma AB Logo
Distributes pharmaceutical medicinal cannabis products across Eastern Europe, with a focus on Poland.
Sweden ODI
OliX Pharmaceuticals, Inc. Logo
Developing RNAi therapeutics for dermatology, ophthalmology, and metabolic diseases via an asiRNA platform.
South Korea 226950
ONCODESIGN Logo
Developing precision oncology solutions for resistant and metastatic cancers.
France ALONC

Talk to a Data Expert

Have a question? We'll get back to you promptly.